Sable Bio specializes in providing Comprehensive Target Safety Intelligence, a platform designed to streamline the assessment of safety risks associated with drug targets. The technology integrates data from various sources, including clinical, genetic, experimental, and textual information, to deliver a comprehensive overview of potential safety issues. By utilizing AI-augmented information extraction and curation, Sable Bio ensures that users receive fresh, relevant data while minimizing the time and expertise required for manual assessments. The platform also features customized ontologies focused on toxicology, allowing for a more nuanced understanding of safety risks.

The platform offers several use cases, including Individual Target Safety Assessment and Target Selection, which enable users to evaluate and rank targets based on associated safety risks. Sable Bio provides quantified safety assessments with interpretable probability scores, taking into account factors such as directionality and expression levels. Additionally, the platform suggests recommended actions and mitigations to address identified risks, including experimental validations. With flexible configurations, users can tailor reports to their specific needs, whether they are in early-stage development or have existing experimental data to incorporate. The API access further enhances usability for data-driven teams, allowing for seamless integration of proprietary insights.

United Kingdom

Prevent target safety failures with unique data insights and cutting-edge approaches.
‍
Better prediction of drug safety could help patients and prevent hugely costly trial failures. Our advanced workflows assess clinical side effects and predict potential risks for drugs in development using a suite of data modalities.

Empower your drug development process with our state-of-the-art solutions. Build trust with industry-leading validation across several proof points.  Gain deeper insights into target safety, minimize risks, and optimize assay validation strategies.

Sable Bio

Company Details